The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Manhattan Scients are completely uncorrelated. Manhattan Scients right now secures a risk of 0.0%. Please verify Manhattan Scients rate of daily change , to decide if Manhattan Scients will be following its current price movements.
Risk-Adjusted Performance
Weakest
Weak
Strong
Over the last 90 days Manhattan Scients has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Manhattan Scients is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
Begin Period Cash Flow
353 K
Total Cashflows From Investing Activities
300 K
Manhattan
Manhattan Scients Relative Risk vs. Return Landscape
If you would invest 0.01 in Manhattan Scients on October 8, 2025 and sell it today you would earn a total of 0.00 from holding Manhattan Scients or generate 0.0% return on investment over 90 days. Manhattan Scients is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Manhattan, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
Expected Return
Risk
Manhattan Scients Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Manhattan Scients' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Manhattan Scients, and traders can use it to determine the average amount a Manhattan Scients' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
Best Portfolio
Best Equity
Good Returns
Average Returns
Small Returns
Cash
Small Risk
Average Risk
High Risk
Huge Risk
MHTX
Based on monthly moving average Manhattan Scients is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Manhattan Scients by adding Manhattan Scients to a well-diversified portfolio.
Manhattan Scients Fundamentals Growth
Manhattan Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Manhattan Scients, and Manhattan Scients fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Manhattan Pink Sheet performance.
Evaluating Manhattan Scients' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Manhattan Scients has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Manhattan Scients has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York. Manhattan Scients operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1 people.
Things to note about Manhattan Scients performance evaluation
Checking the ongoing alerts about Manhattan Scients for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Manhattan Scients help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Manhattan Scients generated a negative expected return over the last 90 days
Manhattan Scients has some characteristics of a very speculative penny stock
Manhattan Scients has a very high chance of going through financial distress in the upcoming years
Manhattan Scients currently holds 143 K in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Manhattan Scients has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Manhattan Scients until it has trouble settling it off, either with new capital or with free cash flow. So, Manhattan Scients' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Manhattan Scients sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Manhattan to invest in growth at high rates of return. When we think about Manhattan Scients' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 50 K. Net Loss for the year was (3.64 M) with profit before overhead, payroll, taxes, and interest of 50 K.
Manhattan Scients currently holds about 386 K in cash with (421 K) of positive cash flow from operations.
Roughly 19.0% of Manhattan Scients outstanding shares are owned by corporate insiders
Evaluating Manhattan Scients' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Manhattan Scients' pink sheet performance include:
Analyzing Manhattan Scients' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Manhattan Scients' stock is overvalued or undervalued compared to its peers.
Examining Manhattan Scients' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Manhattan Scients' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Manhattan Scients' management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Manhattan Scients' pink sheet. These opinions can provide insight into Manhattan Scients' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Manhattan Scients' pink sheet performance is not an exact science, and many factors can impact Manhattan Scients' pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for Manhattan Pink Sheet Analysis
When running Manhattan Scients' price analysis, check to measure Manhattan Scients' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Manhattan Scients is operating at the current time. Most of Manhattan Scients' value examination focuses on studying past and present price action to predict the probability of Manhattan Scients' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Manhattan Scients' price. Additionally, you may evaluate how the addition of Manhattan Scients to your portfolios can decrease your overall portfolio volatility.